Psychoeducational training for schizophrenic patients: Background, procedure and empirical findings

Patient Education and Counseling

Volumn 29, Issue 3, 1996, Pages 257-268

  Hornung, W Peter ^a   Kieserg, Angela ^a   Feldmann, Reinhold ^a   Buchkremer, Gerhard ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

medication management; psychoeducational training; schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; EDUCATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCHIZOPHRENIA; TRAINING;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MALE; PATIENT COMPLIANCE; PATIENT EDUCATION; PROGRAM EVALUATION; PROSPECTIVE STUDIES; PSYCHOTHERAPY, GROUP; SCHIZOPHRENIA;

EID: 0030450497     PISSN: 07383991     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-3991(96)00918-4     Document Type: Article

References (53)

1. [1] Kissling W, Kane TRA, Barnes TRE, Dencker SJ, Fleischhacker WW, Goldstein MJ, Johnson DAW, Marder SR, Müller-Spahn F, Tegeler J, Wistedt B, Woggon B. Guidelines for neuroteptic relapse prevention in schizophrenia: towards a consensus view. In: Kissling W editor. Guidelines for neuroleptic relapse prevention in schizophrenia. Berlin: Springer, 1991.
2. [2] Maurer K, Biehl H. Klinikaufenthalte und produktive Rückfälle bei ersterkrankten Schizophrenen. Determinanten des Zeitverlaufs zwischen stationären Aufnahmen bzw. schizophrenen Rezidiven über fünf Jahre [Rehospitalizations and productive relapses of first onset schizophrenics - determinants of "survival time" between repeated hospitalizations resp. schizophrenic relapses over five years]. Nervenheilkunde 1988; 7: 279-290.
3. [3] Shepherd M, Watt D, Falloon IRH, Smeeton N. The natural history of schizophrenia: a five year follow up study of outcome and prediction in a representive sample of schizophrenics. Cambridge: Psychological Medicine Cambridge Press, 1989.
4. [4] Gmür M. The 12-year clinical course of schizophrenia. Soc Psychiatry Psychiatric Epidemiol 1991; 26: 202-211.
5. [5] Davis JM. Overview: maintenance therapy in psychiatry: I. Schizophrenia. Am J Psychiatry 1975; 132: 1237-1245.
6. [6] Wöller W, Tegeler J. Späte extrapyramidale Hyperkinesien. Klinik-Prävalenz-Pathophysiologie [Tardive dyskinesia: clinical picture, prevalence, and pathophysiology]. Fortschr Neurol Psychiat 1983; 51: 131-157.
7. [7] Schooler NR, Levine J. Strategies for enhancing drug therapy of schizophrenia. Am J Psychiatry 1983; 37: 521-532.
8. [8] Herz MJ, Szymanski HV, Simon JC. Intermittent medication for stable schizophrenic outpatients. An alternative to maintenance medication. Am J Psychiatry 1982; 139: 918-22.
9. [9] Kunar S, Thara R, Rajkumar S. Coping with symptoms of relapse in schizophrenia. Eur Arch Psychiatry Neurol 1989; 239: 213-215.
10. [10] Jolley AG, Hirsch SR, Morrison E, McRink A, Wilson L. Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients. Clinical and social outcome at two years. Br Med J 1990; 301: 837-842.
11. [11] Kane JM, Rifkin A, Woerner M, Reamow G, Sarantakos S, Schiebel D, Ramos-Lorenzi J. Low-dose neuroleptic treatment of outpatient schizophrenics. Arch Gen Psychiatry 1983; 40: 893-896.
12. [12] Johnson DAW, Ludlow JM, Stark K, Taylor RDW. Double-blind comparison of half-dose and standard-dose flupenthixol decanoate in the maintenance treatment of stabilised outpatinets with schizophrenia. Br J Psychiatry 1987; 151: 634-638.
13. [13] Marder SR, van Putten T, Mintz J, Lebell M, McKenzie J, May PRA. Low and conventional dose maintenance therapy with fluphenazine decanoate. Arch Gen Psychiatry 1987; 44: 518-521.
14. [14] Hirsch SR, Jolley AG, Manchanda R, McRink A. Frühzeitige medikamentöse Intervention als Alternative zur Depot-Dauer-Medikation in der Schizophreniebehandlung: Ein vorläufiger Bericht [Target medical intervention as an alternative to depot medication in the treatment of schizophrenia. A preliminary report]. In: Böker W, Brenner HD editors. Bewältigung der Schizophrenie [Coping with schizophrenia], Bern: Huber, 1986.
15. [15] Pietzcker A, Gaebel W, Köpcke W, Linden M, Müller P, Müller-Spahn F, Schüssler G, Tegeler J. A German multicenter study on the neuroleptic long-term therapy of schizophrenic patients. Pharmacopsychiatry 1986; 19: 161-166.
16. [16] Mosher LR, Keith SJ. Psychosocial treatment: individual, group, family, and community support approaches. Schizophr Bull 1980; 6: 10-41.
17. [17] Anderson CM, Hogarty GE, Reiss DJ. Family treatment of adult schizophrenic patients: a psychoeducational approach. Schizophr Bull 1980; 6: 490-505.
18. [18] Goldstein MJ. Psychoeducational and family therapy in relapse prevention. Acta Psychiatr Scand 1994; 89 Suppl 382: 54-57.
19. [19] Brown GW, Birley JLT, Wing J. Influence of family life on the course of schizophrenic disorders: a replication. Br J Psychiatry 1972; 121: 241-258.
20. [20] Vaughn CE, Leff JP. The influence of family and social factors on the course of psychiatric illness: a comparison of schizophrenic and depressed neurotic patients. Br J Psychiatry 1976; 129: 125-137.
21. [21] Hatfield AB. Issues in psychoeducation for families of the mentally ill. Int J Mental Health 1988; 17: 48-64.
22. [22] Bernier MJ. Current perspectives: Psychoeducation: Subset or prototype of the health education model? Patient Educ Couns 1992; 19: 125-127.
23. [23] Zubin J, Spring B. Vulnerability-a new view of schizophrenia. J Abnormal Psychol 1977; 86: 103-126.
24. [24] Vaughan K, Doyle M, McConaghy N, Blaszcynski A, Fox A, Tarrier N. The Sydney intervention trial: a controlled trial of relatives' counselling to reduce schizophrenic relapse. Soc Psychiatry Psychiatric Epidemiol 1992; 27: 16-21.
25. [25] Schulze Mönking H. Self-help groups for families of schizophrenic patients: formation, development and therapeutic impact. Soc Psychiatry Psychiatric Epidemiol 1994; 29: 149-154.
26. [26] Leff J, Kuipers L, Berkowitz R, Eberlein-Fries R, Sturgeon D. A controlled trial of social intervention in the families of schizophrenic patients. Br J Psychiatry 1982; 141: 121-134.
27. [27] Falloon IRH, Boyd JL, McGill CW, Razani J, Moss MB, Gilderman AM. Family management in the prevention of exacerbations of schizophrenia. A Controlled Study. New Eng J Med 1982; 306: 1437-40.
28. [28] Tarrier N, Barrowclough C, Vaughn C, Bamrah JS, Porceddu K, Watts S, Freeman H. The community management of schizophrenia: a controlled trial of a behavioral intervention with families to reduce relapse. Br J Psychiatry 1988; 153: 532-542.
29. [29] Lewandowski L, Buchkremer G. Bifokale therapeutische Gruppenarbeit mit schizophrenen Patienten und ihren Angehörigen, Ergebnisse einer 5 jährigen Katamnese [Bifocal therapeutic group treatment of schizophrenic patients and their relatives. Results of a five year-follow up]. In: Kaschka WP, Joraschky P, Lungershausen E editors. Die Schizophrenien. Biologische und familiendynamische Konzepte zur Pathogenese [Schizophrenic disorders. Biological and family dynamic concepts of pathogenesis]. Berlin: Springer, 1988.
30. [30] Bäuml J, Bals B, Schlag K, Kissling W, Lauter H. Informationszentrierte Angehörigengruppen zur Compliance-Verbesserung bei der Rezidivprophylaxe von schizophrenen Psychosen-Ergebnisse einer 1-Jahres-Katamnese [Compliance improvement by information centered relatives' groups in the relapse prevention of schizophrenic psychoses-results of a one year-follow up]. Zbl Neurol Psychiat 1990; 255: 278.
31. [31] Ascher-Svanum M. A psychoeducational intervention for schizophrenic patients. Patient Educ Couns 1989; 14: 81-87.
32. [32] Eckman TA, Liberman RP, Phipps CC, Blair KE. Teaching medication management skills to schizophrenic patients. J Clin Psychopharmacol 1990; 10: 33-38.
33. [33] Kaluzny Streicker S, Amdur M, Dincin J. Educating patients about psychiatric medications: failure to enhance compliance. Psychosoc Rehabil 1986; 9: 15-28.
34. [34] Wallace CJ, Liberman RP. Social skills training for patients with schizophrenia: a controlled clinical trial. Psychiatry Res 1985; 15: 239-247.
35. [35] Hogarty GE, Anderson CM, Reiss DJ, Kornblith SJ, Greenwald DP, Jarna CD, Madonia MJ. Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare of schizophrenia I. One-year effects. Arch Gen Psychiatry 1986; 43: 633-642.
36. [36] Strachan M. Family intervention for the rehabilitation of schizophrenia. Toward protection and coping. Schizophr Bull 1986; 12: 678-698.
37. [37] Batey SR, Ledbetter JE. Medication education for patients in a partial hospitalization program. J Psychosoc Nurs Ment Health 1982; 20: 7-10.
38. [38] Brown CS, Wright RG, Christensen DB. Association between type of medication, instruction and patients' knowledge, side effects, and compliance. Hosp Community Psychiatry 1987; 38: 55-60.
39. [39] Buchkremer G, van der Ven M, Schulze Mönking H. Medikamentenmitbestimmung-ein psychotherapeutisches Ziel bei schizophrenen Patienten [Medication codetermination - a psychotherapeutic scope for schizophrenic patients]. In: Helmchen H, Hippius H, Tölle R editors. Therapie mit Neuroleptika-Perazin [Neuroleptic therapy - perazine]. Stuttgart: Thieme, 1988.
40. [40] Goldman CHR, Quinn FL. Toward a definition of psychoeducation. Hosp Community Psychiatry 1988; 39: 666-668.
41. [41] Seltzer A, Roncari J, Garfinkel P. Effect of patient education on medication compliance. Can J Psychiatry 1980; 25: 638-45.
42. [42] Bozckowski JA, Zeichner A, DeSanto N. Neuroleptic compliance among schizophrenic outpatients: an intervention outcome report. J Consult Clin Psychol 1985; 53: 666-671.
43. [43] Buchkremer G, Fiedler P. Cognitive versus action orientated treatment: comparison between two psychotherapeutic methods for preventing relapse in schizophrenic patients. Nervenarzt 1987; 58: 481-488.
44. [44] Kieserg A, Hornung WP. Psychoedukatives Training für schizophrene Patienten. Ein Behandlungsprogramm zur Rezidivprophylaxe [Psychoeducational training for schizophrenic patients. A therapeutic program for relapse prevention]. Tübingen: DGVT-Verlag, 1994.
45. [45] Buchkremer G, Windgassen K. Guidelines to psychotherapeutic management of schizophrenic patients. What do the various schools and methods have in common? Psychother Psychosom med Psychol 1987; 12: 401-436.
46. [46] Hornung WP, Buchkremer G, Redbrake M. Codetermination of medication as a step towards improved compliance: The patients' viewpoint. Schizophr Res 1990; 3: 41.
47. [47] Herz MJ, Glazer W, Mirza M, Mostert M, Hafez H. Treating prodromal episodes to prevent relapse in schizophrenia. Br J Psychiatry 1989; 155 (Suppl): 123-127.
48. [48] Herz MI, Melville C. Relapse in schizophrenia. Am J Psychiatry 1980; 137: 801-805.
49. [49] Hornung WP, Holle R, Schulze Mönking H, Klingberg S, Buchkremer G. Psychoeducational-psychotherapeutic treatment of schizophrenic patients and their relatives. Results of a one year-follow up. Nervenarzt 1995; 66: 828-834.
50. [50] Strauss JS, Kokes R, Klerman J, Sacksteder J. Premorbid adjustment in schizophrenia: concepts, measures, and implications. Schizophr Bull 1977; 3: 182-244.
51. [51] American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, revised. Washington DC: American Psychiatric Association.
52. [52] Endicott J, Spitzer RL, Fleiss JL, Cohen J. The Global Assessment Scale: A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976; 33: 766-771.
53. [53] Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10: 799-812.